MRTX - Mirati Therapeutics GAAP EPS of -$3.72 misses by $0.79 February, 28 2022 04:08 PM Mirati Therapeutics Inc. Mirati Therapeutics press release (NASDAQ:MRTX): Q4 GAAP EPS of -$3.72 misses by $0.79. Approx $1.5 billion in cash, cash equivalents, and short-term investments. For further details see: Mirati Therapeutics GAAP EPS of -$3.72 misses by $0.79